Bio-rad laboratories, inc. (BIO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows from operating activities:
Cash received from customers

2,330,635

2,311,925

2,326,836

2,308,628

2,286,732

2,326,310

2,291,851

2,255,073

2,174,835

2,093,948

2,061,476

2,053,654

2,090,599

2,074,024

2,043,017

2,004,617

1,970,012

1,956,084

1,992,469

2,046,649

2,096,552

2,162,520

2,172,502

2,171,172

2,130,319

2,090,030

2,082,065

2,061,635

2,066,888

2,063,805

2,022,812

2,006,988

2,023,081

2,018,755

2,018,640

2,006,107

1,928,563

1,877,483

0

0

0

Cash paid to suppliers and employees

1,821,098

1,818,575

1,887,544

1,914,129

1,953,145

1,989,685

1,980,542

1,954,965

1,909,530

1,916,119

1,873,510

1,841,819

1,850,156

1,808,687

1,817,355

1,766,892

1,784,896

1,730,062

1,732,127

1,779,749

1,789,060

1,806,526

1,820,838

1,818,335

1,815,387

1,804,028

1,772,424

1,740,544

1,695,851

1,664,491

1,618,085

1,632,192

1,632,151

1,639,848

1,642,910

1,600,301

2,362,870

1,536,935

0

0

0

Interest paid, net

22,102

22,330

22,363

22,511

22,784

22,703

22,548

22,636

22,656

22,224

22,958

22,710

22,515

22,756

22,368

22,633

21,451

20,793

19,656

18,952

20,030

20,793

21,802

47,464

49,850

61,233

60,628

46,949

45,704

46,369

46,702

47,664

47,010

56,859

57,108

65,269

103,109

59,834

0

0

0

Income tax payments, net

45,042

45,081

47,208

38,810

63,736

62,414

70,155

80,690

46,577

52,136

40,890

46,423

57,667

38,442

53,442

36,531

22,797

31,715

13,480

18,149

20,527

28,939

42,529

46,101

63,858

71,144

76,006

88,180

82,882

93,697

108,132

97,660

75,387

68,750

43,277

46,042

87,154

55,502

0

0

0

Investment proceeds and miscellaneous receipts, net

31,089

31,673

32,874

32,122

28,721

26,383

25,655

23,549

19,267

18,392

14,575

14,984

14,213

14,597

16,618

16,103

12,445

11,953

14,003

14,048

15,563

15,671

15,197

16,117

16,058

16,760

16,488

16,087

14,367

12,991

10,991

11,111

9,031

9,686

8,556

7,007

4,196

3,625

0

0

0

Excess tax benefits from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

1,500

1,462

2,427

2,465

3,610

3,825

2,139

2,379

1,349

2,678

2,689

2,796

2,720

2,772

2,839

2,654

2,889

2,063

1,946

2,270

3,168

2,274

4,167

4,390

2,928

0

0

0

Proceeds from forward foreign exchange contracts, net

-3,710

285

14,697

14,875

2,903

7,603

-41,037

-31,165

-20,795

-17,724

6,429

12,459

9,134

-1,164

9,140

-4,299

4,500

4,353

14,724

9,481

3,437

7,778

-852

7,818

6,739

1,471

483

1,082

-2,483

2,870

-5,082

-16,653

-9,128

-2,919

1,604

20,468

-198

-3,211

0

0

0

Net cash provided by operating activities

477,800

457,900

403,100

365,600

288,100

285,500

249,828

216,003

200,603

104,100

129,558

152,690

167,345

216,100

157,266

187,938

149,316

186,210

190,474

198,849

237,188

273,312

303,646

267,824

210,689

169,136

184,822

201,332

255,237

266,480

261,740

241,556

278,213

262,735

281,627

297,335

223,422

225,909

0

0

0

Cash flows from investing activities:
Capital expenditures

96,494

98,532

130,808

121,771

126,270

129,825

102,019

100,278

99,184

111,332

130,377

149,522

155,472

141,436

124,310

109,596

110,216

112,000

124,147

126,758

125,498

120,999

108,585

101,570

95,136

106,658

109,441

125,770

142,318

142,869

148,021

136,028

119,733

102,888

0

0

0

-

-

-

-

Proceeds from dispositions of property, plant and equipment

93

129

127

301

4,371

4,315

4,297

4,165

89

86

82

398

412

398

416

71

76

79

-115

-84

115

225

343

464

1,302

1,214

7,346

7,299

6,351

6,325

288

234

211

234

858

985

929

1,190

0

0

0

Payments for acquisitions and long-term investments

-

-

-

-

-

-

-

-

-

-

0

0

78,072

-

12,651

13,244

13,095

4,356

4,472

5,206

44,158

44,627

47,189

48,181

9,362

72,054

69,474

86,737

88,170

39,443

188,319

171,899

170,296

158,538

9,311

27,190

159,374

89,307

0

0

0

Recovery of (payments for) purchases of intangible assets

-

-

-

-

-

3

0

0

0

-

-

-

-

-

-

-

-

1,372

1,366

1,418

4,428

15,479

15,688

15,582

12,595

700

556

1,047

1,998

1,780

1,721

1,526

578

436

1,805

2,193

5,865

4,081

0

0

0

Payments for purchases of intangible assets

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments for purchases of marketable securities and investments

374,226

371,450

351,032

359,633

404,951

371,019

335,716

322,664

275,794

282,656

294,017

272,641

274,891

278,071

339,877

331,628

299,414

294,497

218,579

217,965

227,041

205,746

221,285

208,952

285,016

386,714

458,473

554,993

642,469

680,966

674,081

674,134

605,032

509,310

444,328

368,814

379,293

240,286

0

0

0

Proceeds from maturities of marketable securities and investments

212,037

226,900

247,781

275,129

262,382

225,295

209,609

192,278

197,163

202,247

192,168

177,363

158,415

143,020

151,379

157,411

165,499

170,823

142,480

127,632

139,399

120,390

140,811

178,684

220,442

276,052

290,609

285,426

281,052

327,052

406,006

450,056

420,056

335,781

246,047

201,428

190,325

203,443

0

0

0

Proceeds from sales of marketable securities and investments

-

-

-

-

-

77,029

74,128

92,709

94,713

97,523

101,055

73,835

76,679

76,859

81,721

79,912

71,689

78,664

73,664

71,988

78,679

75,725

71,081

236,066

253,996

289,779

319,313

180,912

163,759

131,295

90,478

54,469

73,839

48,825

0

0

0

-

-

-

-

Proceeds from Sale of Debt Securities, Available-for-sale

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for Previous Acquisition

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from divestiture of a product line

-

-

-

-

-

6,964

6,964

6,919

6,919

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Payments for) proceeds from Other Investing Activities

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-198,598

-208,889

-202,504

-122,104

-190,875

-186,978

-145,250

-130,555

-83,996

-175,572

-212,612

-251,227

-273,414

-213,880

-247,535

-221,341

-189,736

-166,869

-132,535

-151,811

-182,932

-190,511

-180,512

40,929

73,631

919

-19,258

-298,114

-422,383

-400,386

-513,207

-465,094

-395,324

-386,332

-265,991

-271,439

-216,791

-216,512

0

0

0

Cash flows from financing activities:
Net payments on line-of-credit arrangements and notes payable

-

-

-

-

-

-

-

-

-

-36

1

1

1

37

0

0

0

-

-

-

-

-1,560

-296

4

17

48

4

-435

-349

-191

-4,082

-4,172

-1,376

-3,900

-1,323

-781

-2,924

-830

0

0

0

Payments on long-term borrowings

1,821

643

1,853

1,815

3,111

2,961

1,691

1,672

327

316

292

296

302

303

307

307

293

282

278

266

253

253

231

300,223

300,220

300,228

300,302

376

469

620

716

834

1,297

226,835

427,880

430,134

434,064

206,706

0

0

0

Payments for credit agreement renewal fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

242

0

0

0

-

-

-

-

Payments of contingent consideration

2,309

2,477

2,477

2,241

2,241

2,078

2,078

1,846

1,846

3,681

3,681

3,105

3,105

3,500

3,500

3,500

3,500

2,983

5,357

5,357

5,357

2,374

0

12,400

14,900

25,474

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Issuances of common stock for shared-based compensation

17,181

13,113

13,015

10,933

10,261

14,133

21,840

17,938

14,586

14,604

6,074

8,183

11,402

11,280

12,338

10,525

10,498

8,236

11,412

13,164

13,133

15,051

10,205

11,130

11,526

11,237

11,050

10,979

10,282

10,611

10,176

10,003

10,075

14,249

16,744

17,565

17,672

12,730

0

0

0

Proceeds from Sale of Treasury Stock

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from reissuances of treasury stock for shared-based compensation, net

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for purchases of treasury stock

128,005

28,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

1,506

1,462

2,427

2,465

3,610

3,825

2,139

2,379

1,349

2,678

2,689

2,796

2,720

2,772

2,839

2,654

2,889

2,063

1,946

2,270

3,168

2,274

4,167

3,944

2,928

0

0

0

Net cash (used in) provided by financing activities

-123,536

-22,758

-64,978

-62,663

-49,034

-48,680

1,899

1,235

2,183

341

-406

5,331

9,435

9,020

9,919

9,145

9,170

8,581

8,478

8,121

7,868

11,689

11,832

-299,263

-300,781

-311,697

-311,950

-67

1,443

12,588

7,340

6,842

4,902

-213,560

9,695

10,671

12,969

228,745

0

0

0

Effect of Exchange Rate on Cash and Cash Equivalents

-5,722

2,237

-7,859

-1,581

2,710

-655

-952

-5,231

-3,815

-1,094

-5,677

-4,097

-15,634

-12,858

-9,040

-7,224

9,137

16,376

16,319

10,304

-903

-12,790

-2,166

8,181

12,339

9,805

11,722

7,361

520

10,475

-444

2,882

18,113

4,837

15,057

19,511

10,174

18,471

0

0

0

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect

149,906

228,487

127,763

179,283

50,892

49,181

105,547

81,497

115,058

-72,188

-89,171

-97,337

-112,302

-1,652

-89,390

-31,482

-22,113

44,298

82,736

65,463

61,221

81,700

132,800

17,671

-4,122

-131,837

-134,664

-89,488

-165,183

-110,843

-244,571

-213,814

-94,096

-332,320

40,388

56,078

29,774

256,613

0

0

0

Adjustments to reconcile net income to net cash used in operating activities [Abstract]
Net income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Forward foreign exchange contracts, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

Losses (gains) on dispositions of securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

Excess tax benefits from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

1,500

1,462

2,427

2,465

3,610

0

0

0

-

2,678

2,689

2,796

2,720

2,772

2,839

2,654

2,889

2,063

1,946

2,270

3,168

2,274

4,167

4,390

2,928

0

0

0

Changes in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

(Increase) decrease in accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Increase in inventories

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Increase in other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Decrease in accounts payable and other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Decrease in income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Increase (decrease) in Deferred Income Taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease/increase in other long-term assets/liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0